Enokizumab
Enokizumab (MEDI-528) is a monoclonal antibody targeting to interleukin (IL) -9. IL-9 regulates the development of airway inflammation, mucus production, airway hyperresponsiveness, and airway fibrosis largely by increasing mast cell numbers and activity in the airways[1].
Product Specifications
CAS Number
909875-08-7
Product Name Alternative
MEDI-528
UNSPSC
12352203
Target
Interleukin Related
Type
Inhibitory Antibodies
Related Pathways
Immunology/Inflammation
Applications
COVID-19-immunoregulation
Field of Research
Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/enokizumab.html
Purity
99.23
Solubility
10 mM in DMSO
Smiles
[Enokizumab]
Molecular Weight
(145.5 kDa)
References & Citations
[1]Oh CK, et al. Biology of the interleukin-9 pathway and its therapeutic potential for the treatment of asthma. Inflamm Allergy Drug Targets. 2011 Jun;10 (3) :180-6.
Shipping Conditions
Dry Ice
Storage Conditions
Store at -80°C for 2 years
Scientific Category
Inhibitory Antibodies
Clinical Information
Phase 2
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
LC403722 20 µg
GPAT 2 (GPAT2) (NM_207328) Human Over-expression Lysate
Sign In for Pricing
View Details